← Back to Search

Smartphone Application for Asthma Management

N/A
Recruiting
Led By Amy Alman, PhD
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Established mild, moderate, or severe persistent asthma with a diagnosis verified by clinic physicians
At least 12 and less than 18 years at enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a smartphone app designed to help manage asthma, specifically in adolescents. They will be measuring how well the app works, how often it is used, and how accepted it is.

Who is the study for?
This trial is for English-speaking adolescents aged 12-17 with mild to severe persistent asthma, who own an iPhone or Android device. They must be diagnosed by clinic physicians and live in the Tampa Bay area during the trial. It's not for those with other chronic lung diseases, certain disorders like cystic fibrosis, vision impairments that affect app use, mental or developmental disorders impacting self-management, or those involved in the app's development.
What is being tested?
The study tests a smartphone application designed to help teenagers manage their asthma better alongside standard care. Participants will either receive standard care alone or with the addition of this new app. The trial measures how well participants can stick to using the app and its impact on managing their asthma over six months.
What are the potential side effects?
Since this intervention involves a smartphone application rather than medication, traditional side effects are not applicable. However, users may experience technical issues or find it challenging to engage consistently with the app features.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My asthma is persistent and has been confirmed by a doctor.
Select...
I am between 12 and 17 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to app reminders (proportion of app reminders)
Average app usage per day
Mean overall usability score obtained from the Health-ITUES
+3 more
Secondary study objectives
Change in ACT score from baseline to the 6-month end point

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Asthma SMARTExperimental Treatment1 Intervention
Subjects randomized to the intervention arm will be provided with the app to download to their personal iPhone or Android smartphone. Subjects will be asked to use the app every day for 6 months.
Group II: Standard of careActive Control1 Intervention
Subjects randomized to the standard-of-care arm will continue to receive regular care for their condition.

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
427 Previous Clinical Trials
192,581 Total Patients Enrolled
9 Trials studying Asthma
633 Patients Enrolled for Asthma
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,944 Previous Clinical Trials
47,799,782 Total Patients Enrolled
282 Trials studying Asthma
114,373 Patients Enrolled for Asthma
Amy Alman, PhDPrincipal InvestigatorUniversity of South Florida
Marisa Couluris, DOPrincipal InvestigatorUniversity of South Florida
4 Previous Clinical Trials
29 Total Patients Enrolled
Paul Rosen, PhDPrincipal InvestigatorUniversity of Utah

Media Library

Asthma SMART Clinical Trial Eligibility Overview. Trial Name: NCT05572177 — N/A
Asthma Research Study Groups: Asthma SMART, Standard of care
Asthma Clinical Trial 2023: Asthma SMART Highlights & Side Effects. Trial Name: NCT05572177 — N/A
Asthma SMART 2023 Treatment Timeline for Medical Study. Trial Name: NCT05572177 — N/A
~10 spots leftby Jun 2025